How high will the Eloxx Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Eloxx Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Eloxx Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Eloxx Pharmaceuticals, Inc. stock today?

The performance of Eloxx Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Eloxx Pharmaceuticals, Inc. stock fall?

The decline in Eloxx Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Eloxx Pharmaceuticals, Inc. Forecast, price target & analysts

$0.00

0.00%

Nasdaq, Dec 27, 09:00 pm CET

ISIN

US29014R1032

Symbol

ELOX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Eloxx Pharmaceuticals, Inc. Target price 2024 - Analyst rating & recommendation

There are currently no analyst estimates including target prices 2024, ratings or recommendations for the Eloxx Pharmaceuticals, Inc. stock.

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 to 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '22	2023 Estimates
Earnings Per Share $	-16.65	-19.20
	56.36%	15.32%
P/E		negative

The average Eloxx Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2022.

This results in the following potential growth metrics and future valuations:

2022	$-16.65	56.36%
2023	$-19.20 15.32% Unlock

Current	0.00	100.00%

Eloxx Pharmaceuticals, Inc....

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 114.53%

Moderna 77.92%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now